DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/t4gpb2/gilead_sciences) has announced the addition of the "Gilead Sciences Clinical Development Profile" report to their offering.
With a market capitalization greater than $100B, Gilead is fast becoming one of the most influential pharmaceutical companies in the world. The report provides a thorough analysis of Gilead Sciences' R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Gilead's key products.
HOW YOU CAN USE THIS REPORT:
- Pharmaceutical Companies: Identify the clinical and commercial status of competing compounds and understand how these will affect the launch of similar/ competing products.
- Service Providers: Better prepare your business development activities focused on Gilead. Understand their strategic direction, current and potential clinical development pipeline, and historic trial metrics.
Key Topics Covered:
1. Methodology and sources
2. Background and strategy
3. R&D pipeline overview
4. Clinical trial activity
6. FDA submissions
7. Key product profiles
For more information visit http://www.researchandmarkets.com/research/t4gpb2/gilead_sciences